🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPharmacology & MechanismsSo the drug literally changes your brain?? That is wild Page 3

So the drug literally changes your brain?? That is wild

tammy_FL Fri, May 15, 2026 at 2:08 AM 26 replies 905 viewsPage 3 of 6
NeuroNate
Senior Member
2,890
16,789
Dec 2023
Chicago, IL
May 15, 2026 at 7:11 PM#11
sarah_TO said:
Receptor pharmacology relevant to the pharmacology: semaglutide is a GLP-1R agonist with a C-18 fatty acid chain that enables albumin binding (>99%),…

That is right for the common case. Whether it is right for the case being asked about depends on a detail that has not been given.

If somebody has the primary source to hand I would rather cite it than paraphrase it.

47 22jason_paloalto, Dr.LeslieOBGYN, MikeNYC_runner and 44 others
Reply Quote Save Share Report
AttorneyGrant
Member
567
2,890
Apr 2024
Washington, DC
May 15, 2026 at 10:16 PM#12
laura_annarbor said:
The mechanism is more central than most summaries suggest.

Saving this. It is the first explanation that did not require me to already understand it.

Last edited: May 15, 2026 at 11:16 PM
46 21laura_annarbor, JenMemphis, pat_auckland and 43 others
Reply Quote Save Share Report
SteveThurs
Member
523
2,345
Sep 2024
Wisconsin
Online
May 16, 2026 at 1:21 AM#13
sarah_TO said:
Receptor pharmacology relevant to the pharmacology: semaglutide is a GLP-1R agonist with a C-18 fatty acid chain that enables albumin binding (>99%),…

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. The objection nobody has made: this only works if the measurement is doing what we assume it is doing, and that assumption has not been tested here.

45 20SleepFixSam, PurityPaulOR, MaxMetOK and 42 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
PeptideChemSF
Senior Member
1,890
9,012
Jan 2024
San Francisco, CA
May 16, 2026 at 4:26 AM#14

One concrete data point for the thread. Say what you would expect to see if you were wrong, before you look. It is a small discipline and it changes what you notice.

Last edited: May 16, 2026 at 8:26 AM
44 19ricardo_MIA, BrianDallas92, labquiet_amy and 41 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
May 16, 2026 at 7:31 AM#15

Moderator note: a post naming a supplier has been edited. Discuss suppliers in the review sections, not here. No action needed from anybody.

43 18PurityPaulOR, MaxMetOK, MounjBrad and 40 others
Reply Quote Save Share Report

Similar Threads

GLP-1R desensitization — β-arrestin-mediated internalization18 replies
Biased agonism at GLP-1R — Gs vs β-arrestin signaling balance13 replies
Semaglutide albumin binding and the C-18 fatty acid linker17 replies
GIP receptor pharmacology — why GIP agonism enhances GLP-113 replies
Glucagon receptor signaling — hepatic glycogenolysis and lipolysis16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register